News

Innovative Health Initiative - Draft topics for Calls 3 & 4 published

Published on | 3 years ago

Programmes Health

The Innovative Health Initiative (IHI) has published the draft texts of topics under consideration for inclusion in the next calls for proposals on the Future Opportunities page of the website. Currently, the draft topics are under consultation and it is therefore likely that the topics may change considerably between now and the call launch, and applicants should check the final, approved topic texts once the calls are launched.

IHI is planning webinars and a brokerage opportunities around the time of the call launches to help applicants learn more about the topics as well as IHI’s rules and procedures. Herewith an overview of the draft topics:

IHI call 3

Call type: single stage | Scheduled for launch: December 2022

  • Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need
  • Patient generated evidence to improve outcomes, support decision making, and accelerate innovation
  • Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiencies
  • Strengthening the European ecosystem for Advanced Therapy Medicinal Products and other innovative therapeutic modalities for rare diseases
  • Digital health technologies for the prevention and personalised management of mental disorders and their long-term health consequences


IHI call 4

Call type: two stage | Scheduled for launch: early 2023

  • Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical drug safety assessment
  • Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare


More information on IHI's website

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1764 articles available search in articles 

Testimonial

image of Lorcenis - Long Lasting Reinforced Concrete for Energy Infrastructures under Severe Operating Conditions

Lorcenis - Long Lasting Reinforced Concrete for Energy Infrastructures under Severe Operating Conditions

ChemStream is an innovative chemical R&D company, specialized in translating material problems in sustainable formulations with focus on nano-dispersions, functional coatings and inkjet inks. Within LORCENIS they will develop super absorbing polymers (SAPs) to be mixed within the concrete matrices for improving the active internal curing, self-healing and self-sealing properties of the concrete. Grindig SAPs.

ChemStream bvba and Ghent University are involved in Horizon 2020-project for developing long lasting reinforced concrete for energy infrastructures.